Cytek Biosciences (CTKB) Change in Inventory (2020 - 2026)

Cytek Biosciences (CTKB) has 7 years of Change in Inventory data on file, last reported at $1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory rose 8.25% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $5.4 million (up 163.31% YoY), and the FY2025 full-year result was $5.2 million, up 135.54% from the prior year.
• Change in Inventory for Q1 2026 stood at $1.6 million, up from -$2.1 million in the prior quarter.
• Across five years, Change in Inventory topped out at $8.4 million in Q2 2022 and bottomed at -$6.3 million in Q4 2023.
• The 5-year median for Change in Inventory is $1.5 million (2025), against an average of $322529.4.
• The widest annual swing landed in 2022, when Change in Inventory jumped 3143.85%; it then slumped 288.35% in 2024.
• A 5-year view of Change in Inventory shows it stood at -$1.9 million in 2022, then plunged by 236.15% to -$6.3 million in 2023, then surged by 68.42% to -$2.0 million in 2024, then slipped by 2.55% to -$2.1 million in 2025, then soared by 179.33% to $1.6 million in 2026.
• The last three Change in Inventory figures came in at $1.6 million (Q1 2026), -$2.1 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.

Peer Comparison